Related Experiment Video
Updated: Jun 15, 2025
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
NSC-38270 Exhibits Anti-invasive and Pro-apoptotic Effects on Hepatocellular Carcinoma Huh7 Cells
Jihye Seo1, Minseo Park1, Sayeon Cho2
1College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Background/Aim:
Hepatocellular carcinoma (HCC) is a main type of liver cancer with high metastatic potential, and its incidence is steadily increasing worldwide. However, the development of new drugs for the treatment of HCC is still insufficient. This study aimed to determine the anticancer effect of NSC-38270, a natural product, on HCC.
Materials And Methods:
After treating HCC Huh7 cells with NSC-38270, cell growth, wound healing, migration, and invasion assays were conducted. We investigated the effects of NSC-38270 on Twist1, a crucial epithelial-mesenchymal transition (EMT)-related transcription factor. In addition, apoptosis, histone H2A.X activation, and cell morphology assays were performed in Huh7 and immortalized normal liver cells following treatment with NSC-38270.
Results:
NSC-38270 reduced the migration and invasion ability of Huh7 cells, accompanied by a decrease in Twist1. Furthermore, NSC-38270 induced apoptosis in Huh7 cells, whereas apoptosis was not observed in immortalized normal liver cells (THLE-2 cells and Chang liver cells).
Conclusion:
NSC-38270 exhibited significant inhibitory effects on the migration and invasion of Huh7 cells by repressing Twist1. Importantly, it induced cancer cell-specific apoptotic effects. These findings suggest that NSC-38270 holds promising potential as a therapeutic candidate for cancer treatment.
Insights
NSC-38270, a natural product, effectively inhibits hepatocellular carcinoma (HCC) cell migration and invasion by targeting Twist1. It also selectively induces apoptosis in cancer cells, showing therapeutic potential for liver cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) incidence is rising globally, with limited therapeutic options.
- HCC exhibits high metastatic potential, necessitating novel treatment strategies.
- Natural products offer a promising avenue for developing new anticancer drugs.
Purpose of the Study:
- To evaluate the anticancer effects of the natural product NSC-38270 on HCC.
- To investigate NSC-38270's impact on HCC cell migration, invasion, and epithelial-mesenchymal transition (EMT).
- To determine NSC-38270's effect on apoptosis and its specificity in cancer cells.
Main Methods:
- Treatment of HCC Huh7 cells with NSC-38270.
- Assays for cell growth, wound healing, migration, and invasion.
- Investigation of Twist1 expression, apoptosis, and histone H2A.X activation.
Main Results:
- NSC-38270 significantly reduced migration and invasion of Huh7 cells.
- A decrease in the EMT-related transcription factor Twist1 was observed.
- NSC-38270 induced apoptosis specifically in HCC cells, not in normal liver cells.
Conclusions:
- NSC-38270 effectively inhibits HCC cell migration and invasion by repressing Twist1.
- The compound demonstrates cancer cell-specific apoptotic effects.
- NSC-38270 shows significant potential as a therapeutic agent for HCC treatment.
